Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population

Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1547-9.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adenocarcinoma / epidemiology*
  • Adenocarcinoma / genetics*
  • Asian People / genetics*
  • Asian People / statistics & numerical data
  • Carcinoma, Squamous Cell / epidemiology*
  • Carcinoma, Squamous Cell / genetics*
  • Case-Control Studies
  • China
  • Cocarcinogenesis
  • Cohort Studies
  • Esophageal Neoplasms / epidemiology*
  • Esophageal Neoplasms / genetics*
  • Esophageal Neoplasms / immunology
  • Gene Frequency / genetics
  • Genetic Variation / genetics
  • Genetics, Population
  • Humans
  • Interleukin-10 / genetics*
  • Interleukin-2 / genetics*
  • Interleukin-6 / genetics*
  • Polymorphism, Genetic / genetics*
  • Proportional Hazards Models
  • Stomach Neoplasms / epidemiology*
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / immunology
  • Th1 Cells / immunology
  • Th2 Cells / immunology

Substances

  • Interleukin-2
  • Interleukin-6
  • Interleukin-10